Ọgwụ ịgba ọgwụ Ranitidine

Nkọwa dị mkpirikpi:

· Ahịa & Nkwupụta: FOB Shanghai: Mkparịta ụka n'ime mmadụ · Ụgbọ mmiri n'ọdụ ụgbọ mmiri: Shanghai, Tianjin, Guangzhou, Qingdao · MOQ (50mg, 2ml): 300000amps · Usoro ịkwụ ụgwọ: T / T, L / C Product nkọwa mejupụtara ...

  • : A na-etinye Ranitidine ngwa ngwa site na ịgba ọgwụ intramuscular ma nwee bioavailability nke ihe dịka 90 ruo 100%.Mwepụ ọkara ndụ site na plasma dị ihe dị ka awa 2 ruo 3 na ranitidine na-ejikọta ya na ihe dịka 15% nke protein protein.
  • Nkọwa ngwaahịa

    Mkpado ngwaahịa

    ·Ọnụ ahịa & nhota:FOB Shanghai: Mkparịta ụka n'ime mmadụ

    ·Ọdụ ụgbọ mmiri: Shanghai, Tianjin,Guangzhou, Qingdao

    ·MOQ(50mg,2ml):300000 amps

    ·Usoro ịkwụ ụgwọ:T/T, L/C

    Nkọwa ngwaahịa

    Ihe mejupụtara
    Otu ampoule nke ranitidine nwere rannitidine hydrochloride USP XXIII 50 mg.
    Ngosipụta
    Ranitidine bụ onye na-anabata histamine H2-receptor antagonist, Dị ka ọ dị, ọ na-egbochi secretion nke gastric acid ma na-ebelata mmepụta pepsin: egosila na ọ na-egbochi omume ndị ọzọ nke histamine nke ndị na-anabata H2 na-akwado ya, a na-eji ya na njikwa nke ọrịa dị iche iche nke eriri afọ gastro-intestinal. dị ka aspiration syndromes, dyspepsia, gastro-esophageal reflux ọrịa, peptic ọnyá afọ na Zollinger-Ellison syndrome.

    Akpachara anya

    Tupu inye ranitidine ndị ọrịa nwere ọnya gastrle, ekwesịrị ịhapụ ohere nke ịdị njọ ebe ọ bụ na ranitidine nwere ike kpuchie akara ngosi yana igbu oge nyocha.Ekwesịrị inye ndị ọrịa nwere ọrụ gbasara akụrụ na-adịghị mma n'ime obere usoro onunu ogwu.

    Mmetụta ọjọọ

    Mmetụta ndị a na-ahụkarị bụ afọ ọsịsa, isi ọwụwa, isi ọwụwa, na rashes. Mmetụta ọjọọ ndị ọzọ, nke a na-akọ na ọ na-adịkarịghị, bụ mmeghachi omume hypersensilivity na ahụ ọkụ, ogbu na nkwonkwo na myalgia. Nsogbu ọbara gụnyere agranulocytosis ma ọ bụ neutropenia na thrombocytopenia, interstitial nephritis. , na ọrịa obi obi, Otú ọ dị, n'adịghị ka cimetidine, ranitidine nwere obere ma ọ bụ enweghị mgbochi-andiogenic mmetụta, n'agbanyeghị na e nwere ndị dịpụrụ adịpụ akụkọ nke gyhaecomaslia na enweghị ike.

    Usoro onunu ogwu na nchịkwa
    Dabere na ọnọdụ a na-agwọta usoro ọgwụgwọ intramuscular ma ọ bụ intravenous nke a na-emebu bụ 50 mg, nke a na-eme ugboro ugboro kwa awa 6 ruo 8: a ga-eji nwayọọ nwayọọ na-agba ogwu ogwu n'ihe na-erughị nkeji 2 ma gbanye ya ka ọ nwee 50 mg. 20ml maka infusion intravenous intermittent nke akwadoro na UK bụ 25 mg kwa elekere nyere maka awa 2 nke enwere ike ịmegharị kwa awa 6 ruo 8 ọ bụla 6.25mg kwa elekere ka akwadoro maka infusion intravenous na-aga n'ihu n'agbanyeghị na enwere ike iji ọnụego dị elu rụọ ọrụ maka. ọnọdụ dị ka ọrịa Zollinger-Ellison ma ọ bụ ndị ọrịa nọ n'ihe ize ndụ site na mgbakasị ahụ.

    Nchekwa na oge kubie ume
    Ụlọ ahịan'okpuru 25
    3 afọ
    Nkwakọ ngwaahịa

    2ml* 10 amps
    Ntinye uche
    50mg

     


  • Nke gara aga:
  • Osote: